LIFE SCIENCES & HEALTHCARE
Because innovation is everything
With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 270 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
- Technology transfers and IP Licensing
- R&D collaborations
- Patent and trade mark disputes and IP strategy
- Clinical trials
- Privacy and data protection
- Regulatory and data exclusivity
- Corporate transactions (including fundraising, IPOs and M&A)
- Competition law
- e-health, m-health and digitalisation
- Marketing arrangements and advertising
- Pricing and reimbursement
- Public procurement
- Product liability
- Employment
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Related capabilities
Meet the Life Sciences and Healthcare team
See the full team
Discover the world of telemedicine
An international overview of the regulatory legislation
Latest insights
More Insights
Accolades
Helping you navigate the practice and procedure of the Unified Patent Court and Unitary Patent.
LMG Life Sciences Awards EMEA 2022
LMG Life Sciences Awards EMEA 2022
Two Impact Case of the Year Awards
- CE - 450163 Doctolib successful before Conseil d'État
- Pharmaceutical Works Polpharma SA v European Medicines Agency (EMA).
LMG Life Sciences Awards EMEA 2023
Winner of Six Awards:
• EMEA M&A Firm of the Year
• EMEA Patent Litigation Firm of the Year: Medical Devices
• EMEA Venture Capital Firm of the Year
• Netherlands Firm of the Year
• Impact Case of the Year: Fingolimod
• Impact Deal of the Year: Dr Reddy’s Laboratories acquisition of Nimbus Health